C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2002
11/27/2002	CN1382218A 溶瘤腺病毒 Oncolytic adenovirus
11/27/2002	CN1382217A Beta-barrel of lipid miniature lipoxidase
11/27/2002	CN1382216A DNA coding for beta-tubulin and use thereof
11/27/2002	CN1382158A Multiple cytokine-antibody complexes
11/27/2002	CN1382156A PABLO polypeptide that interacts with BCL-XL and uses related thereto
11/27/2002	CN1382059A Method and compositions for prevneting or reducing HIV infection
11/27/2002	CN1382014A Somatic embryogemic regeneration of Acacia mangium
11/27/2002	CN1381562A Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage
11/27/2002	CN1381461A Light chain or heavy chain variable region gene of human liver cancer monoclonal antibody HAb18 and its application
11/27/2002	CN1094976C Tomato spotted wilt virus
11/27/2002	CN1094933C Process for producing taxanes diterpene
11/27/2002	CA2414037A1 Dna sequence regulating plant fruit-specific expression
11/26/2002	US6486131 As diagnostic and therapeutic assays and reagents for detecting and therapy of proliferative disorders arising from, for example, tumorigenic transformation of cells, or other hyperplastic or neoplastic transformation processes
11/26/2002	US6485975 Method for regenerating viable and fertile citrus plants by tissue culture from explants
11/26/2002	US6485972 WNT signalling in reproductive organs
11/26/2002	US6485971 Keratinocyte stem cells
11/26/2002	US6485970 Immunointeractive antibody
11/26/2002	US6485969 Biomaterial derived from follicle basement membranes
11/26/2002	US6485968 Ectoparasite saliva proteins and apparatus to collect such proteins
11/26/2002	US6485967 Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
11/26/2002	US6485966 Hybrid microorganism for use in gene therapy
11/26/2002	US6485965 Replicating or semi-replicating viral constructs, preparation and uses for gene delivery
11/26/2002	US6485960 Polycystic kidney disease 1 gene and uses thereof
11/26/2002	US6485957 DNA encoding the human serine protease EOS
11/26/2002	US6485955 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
11/26/2002	US6485951 Derived from pseudomonas jessenii
11/26/2002	US6485948 Carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme
11/26/2002	US6485935 Structure of the ankyrin binding domain of a α-Na, K-ATPase
11/26/2002	US6485919 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
11/26/2002	US6485911 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 2 (PS-2) gene
11/26/2002	US6485904 DNA encoding a plasminogen activating protein
11/26/2002	US6485724 Immortalized human keratinocyte cell line
11/26/2002	US6485723 Enhanced submucosal tissue graft constructs
11/26/2002	US6485721 Treating diabetes, comprising transplanting artificial skin of biopolymer and skin fibroblasts and/or epidermal cells transformed with a recombinant expression vector expressing human proinsulin and/or insulin
11/26/2002	CA2256766C Materials and methods for the immobilization of bioactive species onto polymeric substrates
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2186034C Highly efficient production and isolation of viral particles
11/26/2002	CA2111573C Cadherin materials and methods
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2051289C Viral mediated destruction of neoplastic cells
11/26/2002	CA2026703C Genetic manipulations with recombinant dna comprising sequences derived from rna virus
11/22/2002	CA2383004A1 Non-anaphylactogenic ige vaccines
11/21/2002	WO2002093177A2 Assays for identifying modulators of rhomboid polypeptides
11/21/2002	WO2002093172A1 Antigen binding fragments for dendritic cell subset and use thereof
11/21/2002	WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092831A2 Method for identifying ligands for g protein coupled receptors
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092825A2 Retroviral vectors for gene therapy
11/21/2002	WO2002092817A1 Functions for d52 and ra006 nucleic acids and polypeptides
11/21/2002	WO2002092816A1 Replication vector showing cell-specific expression
11/21/2002	WO2002092812A1 ARTIFICIAL HUMAN CHROMOSOME CONTAINING HUMAN ANTIBODY μ LIGHT CHAIN GENE
11/21/2002	WO2002092809A1 Novel hexenuronidase, gene coding for the same, and use of these
11/21/2002	WO2002092803A1 Phosphotriesterase from agrobacterium radiobacter p230
11/21/2002	WO2002092795A2 Intracellular bonding of costimulatory molecules
11/21/2002	WO2002092794A2 Isolation method of mesenchymal cells
11/21/2002	WO2002092793A1 Method for obtaining antigen-specific tr1 regulatory lymphocytes
11/21/2002	WO2002092792A2 Antigen-dependent reduction of specific immune responses by influencing co-stimulation
11/21/2002	WO2002092791A1 Tissues or organs for use in xenotransplantation
11/21/2002	WO2002092786A2 A helper dependent adenoviral vector system and methods for using the same
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092778A2 Device and method for three-dimensional spatial localization and functional interconnection of different types of cells
11/21/2002	WO2002092773A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002	WO2002092771A2 Specific binding proteins and uses thereof
11/21/2002	WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002	WO2002092762A2 Cytokine polypeptides
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092758A2 Gastrokines and derived peptides including inhibitors
11/21/2002	WO2002092756A2 Insulin producing cells derived from human embryonic stem cells
11/21/2002	WO2002092741A2 0etergent compositions comprising bacillus subtilis pectate lyases
11/21/2002	WO2002092634A2 Specific antibodies for histamine receptor subclasses
11/21/2002	WO2002092625A2 Moraxella(branhamella) catarrhalis antigens
11/21/2002	WO2002092134A1 Lentiviral vectors encoding clotting factors for gene therapy
11/21/2002	WO2002092054A2 Immune modulation device for use in animals
11/21/2002	WO2002092024A2 Compounds and methods for inhibiting axillary malodour
11/21/2002	WO2002092017A2 Human antipneumococcal antibodies from non-human animals
11/21/2002	WO2002092013A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002	WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002	WO2002091999A2 Treatment for wounds
11/21/2002	WO2002091997A2 Oncolytic virus therapy
11/21/2002	WO2002091995A2 Method to induce neovascular formation and tissue regeneration
11/21/2002	WO2002091994A2 Composition and method for increasing cell density in cell cultures infected with lentivirus
11/21/2002	WO2002091991A2 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use
11/21/2002	WO2002091955A1 Artificial kidney having function of metabolizing protein and mehtod of constructing the same
11/21/2002	WO2002091926A2 Inhibitors of dna methyltransferase isoforms
11/21/2002	WO2002078449A3 Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
11/21/2002	WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002	WO2002072798A9 Fas ligand-expressing hematopoietic cells for transplantation
11/21/2002	WO2002069976A8 Use of ovarian hormone for increasing neural stem cell number
11/21/2002	WO2002064179A3 Bioartificial primarily vascularized tissue matrix, bioartificial primarily vascularized tissue, method for the production thereof and use of the same
11/21/2002	WO2002063938A9 Production and use of dopaminergic cells to treat dopaminergic deficiencies
11/21/2002	WO2002058532A3 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
11/21/2002	WO2002057290A3 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
11/21/2002	WO2002055720A3 Materials and methods relating to protein aggregation in neurodegenerative disease
11/21/2002	WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002	WO2002052014A3 Efficient expression of plasmodium apical membrane antigen 1 in yeast cells
11/21/2002	WO2002046381A3 Method for the prevention or reduction of haze in beverages
11/21/2002	WO2002046359A3 Inducible highly productive raav packaging cell-lines

1 ... 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 ... 1827